Literature DB >> 7862170

v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development.

G Zhang1, C Slaughter, E H Humphries.   

Abstract

In an effort to identify aberrantly expressed genes in v-rel-induced tumors, monoclonal antibodies were developed that reacted selectively with avian B-cell tumors. One antibody, HY78, immunoprecipitated a 120-kDa glycoprotein (p120) from cells that express v-rel. N-terminal amino acid sequencing of p120 identified a 27-amino-acid sequence that is also present in DM-GRASP, an adhesion molecule belonging to the immunoglobulin superfamily. Evidence from tissue distribution, immunological cross-reaction, PCR amplification, cDNA cloning, and DNA sequence shows that p120 is indeed DM-GRASP. Northern (RNA) analysis using a probe from the DM-GRASP gene identified a 5.3-kb transcript in mRNA from bursa, thymus, and brain as well as from v-rel-induced B-cell lymphomas but not from bursal B cells. The induction of this protein by v-rel during the development of bursal B-cell lymphomas appears, therefore, to be ectopic in nature. Overexpression of v-rel or c-rel in chicken embryonic fibroblasts, B-cell lines, and spleen mononuclear cells induces the expression of DM-GRASP. The ratio of DM-GRASP to v-Rel was fivefold higher than that of DM-GRASP/c-Rel in a B-cell line, DT95. Interestingly, the presence of HY78 antibody inhibits the in vitro proliferation of v-rel-transformed cells but not cells that immortalized by myc. These data suggest that DM-GRASP is one of the genes induced during v-rel-mediated tumor development and that DM-GRASP may be involved in the growth of v-rel tumor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862170      PMCID: PMC230405          DOI: 10.1128/MCB.15.3.1806

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension.

Authors:  F R Burns; S von Kannen; L Guy; J A Raper; J Kamholz; S Chang
Journal:  Neuron       Date:  1991-08       Impact factor: 17.173

3.  Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity.

Authors:  T K Kerppola; T Curran
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.

Authors:  C Gélinas; H M Temin
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

5.  The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

Authors:  D W Ballard; W H Walker; S Doerre; P Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; W C Greene
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester.

Authors:  G Voraberger; R Schäfer; C Stratowa
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

7.  The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro.

Authors:  J Y Zhang; W Olson; D Ewert; W Bargmann; H R Bose
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

Review 8.  NF-kappa B, KBF1, dorsal, and related matters.

Authors:  T D Gilmore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

9.  Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.

Authors:  A J Capobianco; D L Simmons; T D Gilmore
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

10.  A widely distributed antigen developmentally regulated in the nervous system.

Authors:  O Pourquié; M Coltey; J L Thomas; N M Le Douarin
Journal:  Development       Date:  1990-08       Impact factor: 6.868

View more
  7 in total

1.  DM-GRASP is necessary for nonradial cell migration during chick diencephalic development.

Authors:  D S Heffron; J A Golden
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

3.  ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.

Authors:  M You; P T Ku; R Hrdlicková; H R Bose
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

4.  Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics.

Authors:  William S Baldwin
Journal:  Nucl Receptor Res       Date:  2019-11-20

5.  The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.

Authors:  D Carrasco; C A Rizzo; K Dorfman; R Bravo
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

6.  Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.

Authors:  Judy A King; Fang Tan; Flaubert Mbeunkui; Zachariah Chambers; Sarah Cantrell; Hairu Chen; Diego Alvarez; Lalita A Shevde; Solomon F Ofori-Acquah
Journal:  Mol Cancer       Date:  2010-10-07       Impact factor: 27.401

7.  Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.

Authors:  Piotr Donizy; Marcin Zietek; Agnieszka Halon; Marek Leskiewicz; Cyprian Kozyra; Rafal Matkowski
Journal:  Diagn Pathol       Date:  2015-07-02       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.